Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jonathan Lewis Hecht, Ph.D., M.D.


This page shows the publications co-authored by Jonathan Hecht and Scott Shainker.
Connection Strength

  1. Immune cell infiltrate at the utero-placental interface is altered in placenta accreta spectrum disorders. Arch Gynecol Obstet. 2020 02; 301(2):499-507.
    View in: PubMed
    Score: 0.895
  2. Down-regulation of soluble fms-like tyrosine kinase 1 expression in invasive placentation. Arch Gynecol Obstet. 2017 Aug; 296(2):257-262.
    View in: PubMed
    Score: 0.746
  3. Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum. Am J Obstet Gynecol. 2021 01; 224(1):B2-B14.
    View in: PubMed
    Score: 0.238
  4. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol. 2020 12; 33(12):2382-2396.
    View in: PubMed
    Score: 0.228
  5. Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol. 2020 09; 223(3):433.e1-433.e14.
    View in: PubMed
    Score: 0.226
  6. Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa. Arch Gynecol Obstet. 2019 12; 300(6):1601-1606.
    View in: PubMed
    Score: 0.220
  7. Hysterectomy for placenta accreta; methods for gross and microscopic pathology examination. Arch Gynecol Obstet. 2016 May; 293(5):951-8.
    View in: PubMed
    Score: 0.169
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.